Health In Tech Announces Voluntary Extension of Lock-Up Period

Rhea-AI Summary

Health In Tech (Nasdaq: HIT) announced on Dec 2, 2025 that its executive officers, vice presidents and board have voluntarily extended their existing lock-up by an additional six months beyond the original twelve-month restriction tied to the company's IPO.

Under the extension, shares held by current executives and directors remain restricted from sale or transfer until June 20, 2026. Health In Tech completed its IPO on Dec 20, 2024, raising gross proceeds of $9.2 million, and says it continues investing in systems, distribution and service expansion.

Positive

• Lock-up extended by 6 months, signaling insider confidence
• Insider shares restricted until June 20, 2026
• Company completed IPO raising $9.2 million in December 2024

Negative

• Insiders have no immediate liquidity until June 20, 2026
• Extended lock-up may limit circulating float in near term

News Market Reaction

-19.02% 3.4x vol

20 alerts

-19.02% News Effect

-16.6% Trough in 4 hr 35 min

-$22M Valuation Impact

$93M Market Cap

3.4x Rel. Volume

On the day this news was published, HIT declined 19.02%, reflecting a significant negative market reaction. Argus tracked a trough of -16.6% from its starting point during tracking. Our momentum scanner triggered 20 alerts that day, indicating elevated trading interest and price volatility. This price movement removed approximately $22M from the company's valuation, bringing the market cap to $93M at that time. Trading volume was very high at 3.4x the daily average, suggesting heavy selling pressure.

Data tracked by StockTitan Argus on the day of publication.

Key Figures

IPO gross proceeds: $9.2 million Original lock-up period: 12 months Lock-up extension: 6 months +2 more

5 metrics

IPO gross proceeds $9.2 million Initial public offering in December 2024

Original lock-up period 12 months Lock-up from final IPO prospectus dated December 20, 2024

Lock-up extension 6 months Voluntary extension by executives, VPs, and Board

Lock-up end date June 20, 2026 Shares of current executive officers and Board restricted until this date

IPO date December 20, 2024 Date of final prospectus for initial public offering

Market Reality Check

Price: $1.12 Vol: Volume 469,751 is below t...

normal vol

$1.12 Last Close

Volume Volume 469,751 is below the 20-day average of 527,182 before this announcement. normal

Technical Price at $1.06 was trading below the 200-day MA of $1.98 ahead of the news.

Peers on Argus

Among close peers, ASUR appeared on the momentum scanner, moving up ~5.02% witho...

1 Up

Among close peers, ASUR appeared on the momentum scanner, moving up ~5.02% without same-day news, while EXFY reacted +3.33% to its own collaboration headline. No broad, synchronized sector move is indicated.

Historical Context

5 past events · Latest: Dec 02 (Positive)

Pattern 5 events

Date	Event	Sentiment	Move	Catalyst
Dec 02	Insider lock-up	Positive	-19.0%	Executives and directors extend IPO lock-up to June 20, 2026.
Nov 11	Blockchain LOI news	Positive	-26.4%	Non-binding LOI and Web Summit panel on HITChain blockchain platform.
Nov 10	Q3 2025 earnings	Positive	+0.3%	Strong revenue and EBITDA growth with rising enrolled employees and partners.
Nov 04	Davos panel news	Positive	-3.1%	Announcement of Davos 2026 panel featuring high-profile speaker on women leaders.
Nov 03	Earnings call notice	Neutral	+1.9%	Scheduling and access details for Q3 2025 earnings call and webcast.

Pattern Detected

Recent news with generally positive tone has often seen negative price reactions, while strong earnings produced only modest gains.

Recent Company History

Over the last few months, Health In Tech reported strong Q3 2025 results on Nov 10, with rapid revenue and EBITDA growth and only a slight +0.34% price reaction. Subsequent news, including Davos event programming on Nov 4 and a blockchain-focused LOI and panel in mid-November, saw price declines of -3.06% and -26.37%. The voluntary lock-up extension on Dec 2 coincided with a -19.02% move, reinforcing a pattern where ostensibly constructive updates have not translated into sustained price strength.

Market Pulse Summary

The stock dropped -19.0% in the session following this news. A negative reaction despite insiders ex...

Analysis

The stock dropped -19.0% in the session following this news. A negative reaction despite insiders extending their lock-up through June 20, 2026 would fit a recent pattern where positive-sounding announcements coincided with declines, including moves of -19.02% and -26.37% after earlier news. Such a response could reflect market focus on other factors disclosed in regulatory filings and earnings, including leadership turnover and growth investments. Historical behavior suggests that sentiment around the name has been fragile following news events.

Key Terms

lock-up restrictions, forward-looking statements

2 terms

lock-up restrictions financial

"have voluntarily agreed to extend the lock-up restrictions on all shares"

A lock-up restriction is a temporary rule that prevents company insiders, early investors and employees from selling their shares for a set period after a public offering. It matters to investors because it limits how many shares can enter the market immediately—like a cooling-off period after a big sale—and when the restriction ends a large increase in available shares can put downward pressure on the stock price or reveal insiders’ confidence in the company.

forward-looking statements regulatory

"Certain statements in this press release are forward-looking statements for purposes"

Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.

AI-generated analysis. Not financial advice.

STUART, Fla., Dec. 2, 2025 /PRNewswire/ -- Health In Tech (Nasdaq: HIT), an Insurtech platform company backed by third-party AI technology, today announced that its executive management team, vice presidents across functions, and  Board of Directors have voluntarily agreed to extend the lock-up restrictions on all shares they hold for an additional six months beyond the original twelve-month lock-up established at the time of the Company's final prospectus issued in connection with its initial public offering on December 20, 2024.

Under this voluntary extension, all shares held by Health In Tech's current executive officers and Board of Directors will remain restricted from sale or transfer until June 20, 2026.

"Our leadership team remains highly committed to the long-term growth of Health In Tech," said Tim Johnson, CEO of Health In Tech. "By choosing to extend their lock-up period, our executives are demonstrating confidence in the Company's outlook and our ongoing initiatives in technology, underwriting automation, and market expansion."

Health In Tech completed its IPO in December 2024, raising gross proceeds of $9.2 million. The Company has since continued to invest in system enhancements, broaden its distribution network, and expand its service offerings across the self-funded healthcare ecosystem.

Use of Forward‑Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech's possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as "may," "will," "should," "design," "target," "aim," "hope," "expect," "could," "intend," "plan," "anticipate," "estimate," "believe," "continue," "predict," "project," "potential," "goal," or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech's actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech's control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech's operations, results of operations, growth strategy and liquidity.

About Health In Tech

Health In Tech (Nasdaq: "HIT") is an Insurtech platform company backed by third-party AI technology, which offers a marketplace that aims to improve processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, and TPAs. Learn more at healthintech.com.

Investor Contact

Investor Relations:
ir@healthintech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/health-in-tech-announces-voluntary-extension-of-lock-up-period-302629745.html

SOURCE Health In Tech

FAQ

What did Health In Tech (HIT) announce on December 2, 2025?

Health In Tech announced executives, vice presidents and the board voluntarily extended their share lock-up by six months to June 20, 2026.

When does the HIT insider lock-up now expire?

The extended lock-up for insider-held shares expires on June 20, 2026.

How long was the original HIT IPO lock-up and when was the IPO?

The original lock-up was 12 months tied to the IPO completed on December 20, 2024.

How much did Health In Tech raise in its December 2024 IPO (HIT)?

Health In Tech raised gross proceeds of $9.2 million in its December 2024 IPO.

What does the HIT lock-up extension mean for shareholders?

The extension limits insider share sales until June 20, 2026, which may reduce near-term insider selling pressure.